Latest Breaking News On - Mersana therapeutics company profile - Page 1 : comparemela.com

Mersana Therapeutics, Inc (NASDAQ:MRSN) Sees Significant Decline in Short Interest

Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 8,990,000 shares, a drop of 17.7% from the April 30th total of 10,920,000 shares. Based on an average trading volume of 2,150,000 shares, the days-to-cover ratio […]

Robertw bairdJpmorgan chase coMerck kgaaAsana biosciencesAcadian asset managementJanssen biotech incRussell investments group ltdMersana therapeutics company profileWalleye tradingMersana therapeutics incPricet rowe associates incMerck kgaVanguard group incMersana therapeuticsGet free reportTruist financial

Mersana Therapeutics, Inc (NASDAQ:MRSN) Given Consensus Recommendation of Moderate Buy by Brokerages

Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have earned an average rating of “Moderate Buy” from the seven ratings firms that are covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year price […]

Robertw bairdVictory capital management incJpmorgan chase coRussell investments group ltdSg americas securitiesNisa investment advisorsMersana therapeutics company profileJanssen biotech incAsana biosciencesMersana therapeutics incMerck kgaaMerck kgaMersana therapeuticsGet free reportCapital managementInvestment advisors

Mersana Therapeutics (NASDAQ:MRSN) Posts Quarterly Earnings Results, Beats Expectations By $0 02 EPS

Mersana Therapeutics (NASDAQ:MRSN) Posts Quarterly Earnings Results, Beats Expectations By $0 02 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Janssen biotech incMerck kgaaMersana therapeutics company profileAsana biosciencesMerck kgaMersana therapeutics incJpmorgan chase coMersana therapeuticsGet free reportJanssen biotechAres tradingMersana therapeutics daily

Brokerages Set Mersana Therapeutics, Inc (NASDAQ:MRSN) Price Target at $6 29

Brokerages Set Mersana Therapeutics, Inc (NASDAQ:MRSN) Price Target at $6 29
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdMerck kgaMerck kgaaAffinity asset advisorsNewtyn managementMersana therapeutics incJpmorgan chase coMersana therapeutics company profileJanssen biotech incAsana biosciencesAcadian asset managementWalleye capitalMersana therapeuticsGet free reportMarketbeat ratingsAsset advisors

Readystate Asset Management LP Makes New Investment in Mersana Therapeutics, Inc (NASDAQ:MRSN)

Readystate Asset Management LP acquired a new position in Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 295,038 shares of the company’s stock, valued at approximately $684,000. Readystate Asset Management LP owned 0.24% […]

United statesRobertw bairdMersana therapeutics incMerck kgaaAsana biosciencesVictory capital management incMerck kgaMersana therapeutics company profileJanssen biotech incSecurities exchange commissionReadystate asset managementMersana therapeuticsFree reportAsset managementCapital managementPublic employees retirement system